Harvard Catalyst Search is currently experiencing problems. We are working to restore it as quickly as possible. Thank you for your patience.
We are experiencing problems with system email notifications. If you have questions please email feedback@catalyst.harvard.edu.

The second Harvard Institute of Translational Immunology (HITI)/Helmsley Trust Pilot Grant RFA – focused on Crohn’s disease – will be available on 12/16/10

Posted December 9, 2010

On December 16, 2010, Harvard Institute of Translational Immunology (HITI) and the Leona M. and Harry B. Helmsley Charitable Trust will release their second Request for Applications (RFA), this one focused on Crohn’s disease.

Any investigator with a Harvard faculty appointment, regardless of degree or institutional affiliation, is eligible to apply for these one-year grants. Award amounts will range from $50,000 to $200,000.

Complete information on this opportunity, including the full RFA, will be available on the Harvard Catalyst website on December 16. Investigators are asked to wait until the full RFA is available before making any inquiries regarding the specific research topics supported by the grant program.

HITI is a newly-established collaborative effort – recently announced by HMS Dean Jeffrey Flier, MD – which will bring together basic, translational, and clinical investigators from across the Harvard community to develop interdisciplinary approaches for elucidating mechanisms of immune-mediated diseases.

Established in 1999, the Leona M. and Harry B. Helmsley Charitable Trust continues Mr. and Mrs. Helmsley’s remarkable philanthropic legacy. The Trust supports a broad spectrum of healthcare and medical research-based programs, including innovative and collaborative funding for research on Crohn’s disease.